These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27018250)

  • 1. Functional interaction between nonreceptor tyrosine kinase c-Abl and SR-Rich protein RBM39.
    Mai S; Qu X; Li P; Ma Q; Liu X; Cao C
    Biochem Biophys Res Commun; 2016 Apr; 473(1):355-360. PubMed ID: 27018250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation.
    He X; Zheng Z; Song T; Wei C; Ma H; Ma Q; Zhang Y; Xu Y; Shi W; Ye Q; Zhong H
    Oncogene; 2010 Apr; 29(15):2238-51. PubMed ID: 20101225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global regulation of alternative RNA splicing by the SR-rich protein RBM39.
    Mai S; Qu X; Li P; Ma Q; Cao C; Liu X
    Biochim Biophys Acta; 2016 Aug; 1859(8):1014-24. PubMed ID: 27354116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase.
    Tani K; Sato S; Sukezane T; Kojima H; Hirose H; Hanafusa H; Shishido T
    J Biol Chem; 2003 Jun; 278(24):21685-92. PubMed ID: 12672821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1.
    Sato M; Maruoka M; Yokota N; Kuwano M; Matsui A; Inada M; Ogawa T; Ishida-Kitagawa N; Takeya T
    FEBS Lett; 2011 Mar; 585(6):834-40. PubMed ID: 21320496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.
    Barilá D; Mangano R; Gonfloni S; Kretzschmar J; Moro M; Bohmann D; Superti-Furga G
    EMBO J; 2000 Jan; 19(2):273-81. PubMed ID: 10637231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage.
    Yuan ZM; Shioya H; Ishiko T; Sun X; Gu J; Huang YY; Lu H; Kharbanda S; Weichselbaum R; Kufe D
    Nature; 1999 Jun; 399(6738):814-7. PubMed ID: 10391251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction between DNA-PK and c-Abl in response to DNA damage.
    Kharbanda S; Pandey P; Jin S; Inoue S; Bharti A; Yuan ZM; Weichselbaum R; Weaver D; Kufe D
    Nature; 1997 Apr; 386(6626):732-5. PubMed ID: 9109492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERalpha and CAPERbeta.
    Dowhan DH; Hong EP; Auboeuf D; Dennis AP; Wilson MM; Berget SM; O'Malley BW
    Mol Cell; 2005 Feb; 17(3):429-39. PubMed ID: 15694343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonreceptor tyrosine kinase c-Abl phosphorylates Runx1 and regulates Runx1-mediated megakaryocyte maturation.
    Liu H; Cui Y; Wang GF; Dong Q; Yao Y; Li P; Cao C; Liu X
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1060-1072. PubMed ID: 29730354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homodimerization of the c-Abl protein tyrosine kinase.
    Wei L; Liu X; Yi YP; Li CF; Wang YL; Cao C
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):698-702. PubMed ID: 16285507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes.
    Agami R; Shaul Y
    Oncogene; 1998 Apr; 16(14):1779-88. PubMed ID: 9583676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Abl tyrosine kinase regulates c-fos gene expression via phosphorylating RNA polymerase II.
    Jing Y; Song Z; Wang M; Tang W; Hao S; Zeng X
    Arch Biochem Biophys; 2005 May; 437(2):199-204. PubMed ID: 15850559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
    Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
    Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.
    Georgiakaki M; Chabbert-Buffet N; Dasen B; Meduri G; Wenk S; Rajhi L; Amazit L; Chauchereau A; Burger CW; Blok LJ; Milgrom E; Lombès M; Guiochon-Mantel A; Loosfelt H
    Mol Endocrinol; 2006 Sep; 20(9):2122-40. PubMed ID: 16645042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.